Organ-on-a-Chip Approach for Accelerating Blood–Brain Barrier Nanoshuttle Discovery
Орган-на-чипе для ускорения разработки наношаттлов через гематоэнцефалический барьер
2024-05-22
SCID: 54.1/qnsxrwbw
Discuss with AI
blood–brain barrierendothelial glycocalyxnanoshuttlesorgan-on-a-chiptransendothelial transport
Figures from the paper
Abstract (AI)
Organ-on-a-chip, which recapitulates the dynamics of in vivo vasculature, has emerged as a promising platform for studying organ-specific vascular beds. However, its practical advantages in identifying vascular-targeted drug delivery systems (DDS) over traditional in vitro models remain underexplored. This study demonstrates the reliability and efficacy of the organ-on-a-chip in screening efficient DDS by comparing its performance with that of a conventional transwell, both designed to simulate the blood–brain barrier (BBB). The BBB nanoshuttles discovered through BBB Chip-based screening demonstrated superior functionality in vivo compared to those identified using transwell methods. This enhanced effectiveness is attributed to the BBB Chip’s accurate replication of the structure and dynamics of the endothelial glycocalyx, a crucial protective layer within blood vessels, especially under shear stress. This capability of the BBB Chip has enabled the identification of molecular shuttles that efficiently exploit the endothelial glycocalyx, thereby enhancing transendothelial transport efficacy. Our findings suggest that organ-on-a-chip technology holds considerable promise for advancing research in vascular-targeted DDS due to its accurate simulation of molecular transport within endothelial systems.
Key Findings
1
Chip-based screening identified molecular shuttles that exploit the endothelial glycocalyx and enhance transendothelial transport.
2
Nanoshuttles identified using the BBB Chip demonstrated superior in vivo functionality compared with nanoshuttles discovered through transwell screening.
3
The BBB Chip more accurately reproduces endothelial glycocalyx structure and dynamics, particularly under physiologically relevant shear stress.
4
The findings support organ-on-a-chip technology as a promising platform for developing vascular-targeted delivery systems.
5
The study compares a blood–brain barrier organ-on-a-chip with a conventional transwell model for screening vascular-targeted drug delivery systems.
Research Object
blood–brain barrier nanoshuttles and their delivery across an organ-on-a-chip BBB model
Research Subject
the screening reliability and transendothelial transport efficacy of vascular-targeted drug delivery systems, particularly the role of endothelial glycocalyx structure and shear-stress dynamics
Publication Details
Publication Date
2024-05-22
Journal
Publisher
ISSN
Cited by
34
Access Type
Author Information
Download PDF
Subscribe to digest